Literature DB >> 8427079

Hallervorden-Spatz disease: MR and pathologic findings.

M Savoiardo1, W C Halliday, N Nardocci, L Strada, L D'Incerti, L Angelini, V Rumi, J D Tesoro-Tess.   

Abstract

PURPOSE: To compare the MR findings of eight cases with clinical diagnosis of Hallervorden-Spatz disease (HSD) with the pathologic findings of two other cases of HSD.
MATERIALS AND METHODS: The eight imaged cases were studied with 0.5-T (seven cases) and/or 1.5-T (five cases) units. Six patients also had CT scans. The two other cases with proven HSD had detailed histologic evaluation.
RESULTS: The 1.5-T findings showed abnormalities confined to the pallidum, which presented a diffuse low signal intensity in T2-weighted images, and an anteromedial area of high signal intensity (eye-of-the-tiger sign). In 0.5-T studies, low signal intensity was less evident and poorly detectable in spin echo, but gradient-echo images could enhance its demonstration; the area of high signal intensity was always well demonstrated. In three cases (three with 1.5 T, one with 0.5 T) a central spot of low signal intensity was seen in this area. The pathologic cases, in addition to neuroaxonal swellings and iron deposits, exhibited areas of "loose" tissue with vacuolization and lesser amounts of iron in the anteromedial part of the pallidum, in a location corresponding to the area of high signal intensity of the imaged cases.
CONCLUSION: Comparison of MR findings with the pathologic studies demonstrates that the low signal intensity in T2-weighted images at 1.5 T corresponds to iron deposits in a dense tissue, and that the high signal intensity of the eye-of-the-tiger sign corresponds to an area of loose tissue with vacuolization. No correlation was found in the two pathologic cases for the central spot of low signal intensity.

Entities:  

Mesh:

Year:  1993        PMID: 8427079      PMCID: PMC8334456     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  15 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology.

Authors:  J E Galvin; B Giasson; H I Hurtig; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Pantothenate kinase 2 mutation with classic pantothenate-kinase-associated neurodegeneration without 'eye-of-the-tiger' sign on MRI in a pair of siblings.

Authors:  Zarazuela Zolkipli; Hisham Dahmoush; Dawn E Saunders; W K Kling Chong; Robert Surtees
Journal:  Pediatr Radiol       Date:  2006-06-07

4.  Pantothenate kinase-associated neurodegeneration with increased lentiform nuclei cerebral blood flow.

Authors:  M Koyama; A Yagishita
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

5.  Cerebral blood flow in dystonia due to pantothenate kinase-associated neurodegeneration.

Authors:  Peter Stoeter; Pedro Roa-Sanchez; Cesar F Gonzalez; Herwin Speckter; Jairo Oviedo; Pamela Bido
Journal:  Neuroradiol J       Date:  2020-08-27

Review 6.  Imaging the adult brain.

Authors:  I Moseley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

7.  MR imaging of cerebral cortical involvement in aceruloplasminemia.

Authors:  Marina Grisoli; Alberto Piperno; Luisa Chiapparini; Raffaella Mariani; Mario Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

8.  Iron in neurodegenerative disorders.

Authors:  D. Berg; G. Becker; P. Riederer; O. Riess
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

9.  Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings.

Authors:  R Nuri Sener
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

10.  Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome.

Authors:  J E Nielsen; L N Jensen; K Krabbe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.